Another piece of evidence of a negative regulation of NRF2 by miRNAs was provided by Wang and colleagues, when they observed that miR-153 acts as an oncogenic effector of the apoptosis, thus reinforcing the proliferation ability of breast cancer cells via suppression of NRF2 and its downstream ARE genes’ expression [92]. This evidence concerns the gene NFE2L2 and breast carcinoma.